Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 2:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 2
1 (50.0%)Rewards for Cannabis Abstinence-study
Not Applicable
Recruiting
- Conditions
- Cannabis Use Disorder
- First Posted Date
- 2023-05-01
- Last Posted Date
- 2025-07-31
- Lead Sponsor
- Parnassia Addiction Research Centre
- Target Recruit Count
- 154
- Registration Number
- NCT05836207
- Locations
- 🇳🇱
Jellinek, Stichting Arkin B.V., Amsterdam, Netherlands
🇳🇱IrisZorg, Arnhem, Netherlands
🇳🇱Antes Youz, Rotterdam, Netherlands
Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder
Phase 2
Not yet recruiting
- Conditions
- Cocaine Use Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-09-07
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- Parnassia Addiction Research Centre
- Target Recruit Count
- 204
- Registration Number
- NCT05529927
News
No news found